AGP

Artia Global Partners Portfolio holdings

AUM $389M
This Quarter Return
+20.24%
1 Year Return
+34.68%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$290M
AUM Growth
+$290M
Cap. Flow
+$33.3M
Cap. Flow %
11.48%
Top 10 Hldgs %
66.21%
Holding
43
New
10
Increased
7
Reduced
4
Closed
8

Top Buys

1
IMGN
Immunogen Inc
IMGN
$10.3M
2
APLS icon
Apellis Pharmaceuticals
APLS
$9.38M
3
SRPT icon
Sarepta Therapeutics
SRPT
$8.84M
4
ETNB icon
89bio
ETNB
$8.82M
5
ROIV icon
Roivant Sciences
ROIV
$6.72M

Top Sells

1
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
$16.1M
2
BIIB icon
Biogen
BIIB
$7.9M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
$6.28M
4
LLY icon
Eli Lilly
LLY
$5.03M
5
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$3.64M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PCVX icon
26
Vaxcyte
PCVX
$4B
$1.93M 0.66%
38,555
+15,796
+69% +$789K
CBAY
27
DELISTED
Cymabay Therapeutics
CBAY
$1.85M 0.64%
169,277
– –
PLRX icon
28
Pliant Therapeutics
PLRX
$101M
$1.81M 0.62%
+100,000
New +$1.81M
CRL icon
29
Charles River Laboratories
CRL
$8.04B
$1.45M 0.5%
6,905
– –
TYRA icon
30
Tyra Biosciences
TYRA
$675M
$771K 0.27%
45,253
– –
WAT icon
31
Waters Corp
WAT
$18B
$758K 0.26%
2,845
– –
BMEA icon
32
Biomea Fusion
BMEA
$116M
$559K 0.19%
+25,452
New +$559K
MOR
33
DELISTED
MorphoSys AG American Depositary Shares
MOR
$325K 0.11%
+43,499
New +$325K
GRTS
34
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$186K 0.06%
+95,170
New +$186K
ALT icon
35
Altimmune
ALT
$338M
– –
0
– –
AMLX icon
36
Amylyx Pharmaceuticals
AMLX
$836M
– –
-8,339
Closed -$245K
AMRN
37
Amarin Corp
AMRN
$311M
– –
-256,800
Closed -$385K
FGEN icon
38
FibroGen
FGEN
$47.8M
– –
-51,795
Closed -$966K
LEGN icon
39
Legend Biotech
LEGN
$6.41B
– –
-5,000
Closed -$241K
LRMR icon
40
Larimar Therapeutics
LRMR
$310M
– –
-38,057
Closed -$172K
VRNA
41
Verona Pharma
VRNA
$9.16B
– –
-90,451
Closed -$1.82M
KRTX
42
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
– –
-88,831
Closed -$16.1M
RETA
43
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-40,000
Closed -$3.64M
1
2